II
INNOVIVA INC
INVA· Health Care· PharmaceuticalsS&P 600
Close · 13/11/2026
19.03
1D
+0.32%52-week range
18.66 – 25.15
Volume
5,60,900.00
Price history
INVA
15/10/2026 to 13/11/2026
O 19.11 H 19.23 L 18.95
1W-0.37%
1M-8.77%
3M-9.21%
6M-13.38%
1Y-14.59%
3Y+38.30%
5Y+5.02%
MAX+25.03%
Fundamentals
as of 13/11/2026- Market cap
- $1.35B
- Shares out
- 71.08M
- P/E (trailing)
- 6.99
- P/E (forward)
- 8.61
- EPS (trailing)
- 2.72
- Dividend yield
- 0.00%
- Beta
- 0.37
- Profit margin
- 44.13%
- P/B
- 1.19
- Return on equity
- 17.01%
SEC financial statements
57 quarterly and 17 annual periods through 30/09/2026.
Details
- Ticker
- INVA
- Index
- SP600
- Sector
- Health Care
- Industry
- Pharmaceuticals
- HQ
- -
Last close 13/11/2026.
Tracked by Congress
1 filer · 0 on watchlist · 0 buys · 2 sells · ?: 2
- 25/03/2025George WhitesidesSellInnoviva, Inc. - Common Stock$250,001–$500,000
- 24/03/2025George WhitesidesSellInnoviva, Inc. - Common Stock$50,001–$100,000